Israeli Company SpliSense gets Fda approval for cystic fibrosis treatment

Israeli biopharmaceutical company, SpliSense, announced that the US Food and Medicine Administration (FDA) and the European Medicines Agency have designated the cystic fibrosis treatment technology as an “orphan drug” (EMA). The FDA and EMA designate medicines and biologic technologies as orphan drugs when they are intended to treat rare diseases. “The orphan designations we received […]

Continue Reading

The G7, the E3 and Iran

Will Iran acquire a nuclear weapon? The 40th Flight Test Squadron at Eglin Air Force Base, Fla., prepares to release a GBU-72 Advanced 5K Penetrator bomb for the first time, Oct. 7, 2021. (Samuel KingU.S. Air Force) by Neville Teller Much of the world is growing increasingly impatient as Iran plays for time on the […]

Continue Reading